Large-scale meta-analysis of genetic studies in ischemic stroke: Five genes involving 152,797 individuals

Indian Journal of Human Genetics

Volumn 17, Issue 3, 2011, Pages 212-217

  Hamzi, Khalil ^a   Tazzite, Amal ^a   Nadifi, Sellama ^a  

^a HASSAN II UNIVERSITY   (Morocco)

Author keywords

Angiotensin I converting enzyme; apolipoprotein E; factor II prothrombin; factor V Leiden; meta analysis; MTHFR; stroke

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); APOLIPOPROTEIN E; BLOOD CLOTTING FACTOR 5 LEIDEN; DIPEPTIDYL CARBOXYPEPTIDASE; PROTHROMBIN;

ARTICLE; BRAIN ISCHEMIA; DNA POLYMORPHISM; GENE DELETION; GENE EXPRESSION PROFILING; GENE INSERTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; META ANALYSIS; SYSTEMATIC REVIEW;

EID: 84856371759     PISSN: 09716866     EISSN: 1998362X     Source Type: Journal    
DOI: 10.4103/0971-6866.92105     Document Type: Article

References (47)

1. Flossmann E, Schulz UG, Rothwell PM Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke. 2004 Jan;35(1):212-27. (Pubitemid 38057622)
2. Dichgans M, Markus HS . Genetic association studies in stroke: methodological issues and proposed standard criteria. Stroke. 2005 Sep;36(9):2027-31. (Pubitemid 41266548)
3. Dichgans M. Genetics of ischaemic stroke. Lancet Neurol. 2007 Feb;6(2):149-61. (Pubitemid 46097541)
4. Meschia JF, Brott TG, Brown RD Jr. Genetics of cerebrovascular disorders. Mayo Clin Proc. 2005 Jan;80(1):122-32. (Pubitemid 40076003)
5. Ariyaratnam R, Casas JP, Whittaker J, Smeeth L, Hingorani AD, Sharma P. Genetics of ischaemic stroke among persons of non-European descent: a meta-analysis of eight genes involving approximately 32,500 individuals. PLoS Med. 2007 Apr;4(4):e131.
6. Szolnoki Z, Somogyvari F, Kondacs A, Szabo M, Fodor L. Evaluation of the interactions of common genetic mutations in stroke subtypes. J Neurol 2002;249:1391-7. (Pubitemid 35217660)
7. Peterlin B, Petrovic D, Zorc M, Keber I. Deletion/insertion polymorphism in the angiotension-converting enzyme gene as a risk factor in the Slovenian patients with coronary heart disease. Pflugers Arch 2000;439(suppl):R40-1.
8. Markus H. Risk of stroke in asymptomatic carotid stenosis. Lancet. 1995 Mar 18;345(8951):721.
9. Kostulas K, Huang WX, Crisby M, Jin YP, He B, Lannfelt L, Eggertsen G, Kostulas V, Hillert J. An angiotensinconverting enzyme gene polymorphism suggests a genetic distinction between ischaemic stroke and carotid stenosis. Eur J Clin Invest. 1999 Jun;29(6):478-83. (Pubitemid 29271637)
10. Pfohl M, Fetter M, Koch M, Barth CM, Rüdiger W, Häring HU. Association between angiotensin I-converting enzyme genotypes, extracranial artery stenosis, and stroke. Atherosclerosis. 1998 Sep;140(1):161-6. (Pubitemid 28378466)
11. Zee RY, Ridker PM, Stampfer MJ, Hennekens CH, Lindpaintner K. Prospective evaluation of the angiotensinconverting enzyme insertion/deletion polymorphism and the risk of stroke. Circulation. 1999 Jan 26;99(3):340-3. (Pubitemid 29051257)
12. Casas JP, Hingorani AD, Bautista LE, Sharma P. Metaanalysis of genetic studies in ischemic stroke: Thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch Neurol 2004;61:1652-61. (Pubitemid 39463422)
13. Zhang XF, Attia J, D'Este C, Yu XH.Prevalence and magnitude of classical risk factors for stroke in a cohort of 5092 Chinese steelworkers over 13.5 years of follow-up. Stroke. 2004 May;35(5):1052-6. Epub 2004 Apr 8. (Pubitemid 38543515)
14. Ueda T, Hatakeyama T, Sakaki S, Ohta S, Kumon Y, Uraoka T. Changes in coagulation and fibrinolytic system after local intra-arterial thrombolysis for acute ischemic stroke. Neurol Med Chir (Tokyo). 1995 Mar;35(3):136-43.
15. Cato AC, Wade E. Molecular mechanisms of antiinflammatory action of glucocorticoids. Bioessays. 1996 May;18(5):371-8. Review. (Pubitemid 126599962)
16. Kario K, Kanai N, Saito K, Nago N, Matsuo T, Shimada K.Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives. Circulation. 1996 May 1;93(9):1630-3. (Pubitemid 26131337)
17. Pezzini A, Del Zotto E, Magoni M, Costa A, Archetti S, Grassi M, et al. Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale. Stroke 2003;34:28-33. (Pubitemid 36070795)
18. Smiles AM, Jenny NS, Tang Z, Arnold A, Cushman M, Tracy RP. No association of plasma prothrombin concentration or the G20210A mutation with incident cardiovascular disease: Results from the Cardiovascular Health Study. Thromb Haemost 2002;87:614-21. (Pubitemid 34302949)
19. Gomez Garcia EB, van Goor MP, Leebeek FW, Brouwers GJ, Koudstaal PJ, Dippel DW. Elevated prothrombin is a risk factor for cerebral arterial ischemia in young adults. Clin Neurol Neurosurg 2002;104:285-8. (Pubitemid 34828279)
20. Hankey GJ, Eikelboom JW, van Bockxmeer FM, Lofthouse E, Staples N, Baker RI. Inherited thrombophilia in ischemic stroke and its pathogenic subtypes. Stroke 2001;32: 1793-9. (Pubitemid 32772210)
21. Lopaciuk S, Bykowska K, Kwiecinski H, Mickielewicz A, Czlonkowska A, Mendel T, et al. Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke. Clin Appl Thromb Hemost 2001;7:346-50. (Pubitemid 32988903)
22. Egan RA, Kuyl JM, Press R, Lutsep HL. Lack of prothrombin gene mutation in young stroke patients. J Stroke Cerebrovasc Dis 2000;9:229-31. (Pubitemid 32046071)
23. Voetsch B, Damasceno BP, Camargo EC, Massaro A, Bacheschi LA, Scaff M, et al. Inherited thrombophilia as a risk factor for the development of ischemic stroke in young adults. Thromb Haemost 2000;83:229-33. (Pubitemid 30093224)
24. Margaglione M, D'Andrea G, Colaizzo D, Cappucci G, del Popolo A, Brancaccio V, Ciampa A, Grandone E, Di Minno G. Coexistence of factor V Leiden and Factor II A20210 mutations and recurrent venous thromboembolism. Thromb Haemost. 1999 Dec;82(6):1583-7.
25. Ridker PM. Duration and intensity of anticoagulation among patients with genetic predispositions to venous thrombosis. Curr Cardiol Rep. 1999 Jul;1(2):88-90.
26. Iniesta JA, Corral J, González-Conejero R, Rivera J, Vicente V.Prothrombotic genetic risk factors in patients with coexisting migraine and ischemic cerebrovascular disease. Headache. 1999 Jul-Aug;39(7):486-9. (Pubitemid 29400300)
27. Nowak-Göttl U, Sträter R, Heinecke A, Junker R, Koch HG, Schuierer G, von Eckardstein A. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood. 1999 Dec 1;94(11):3678-82.
28. Berge E, Haug KB, Sandset EC, Haugbro KK, Turkovic M, Sandset PM. The factor V Leiden, prothrombin gene 20210GA, methylenetetrahydrofolate reductase 677CT and platelet glycoprotein IIIa 1565TC mutations in patients with acute ischemic stroke and atrial fibrillation. Stroke. 2007 Mar;38(3):1069-71. (Pubitemid 46568476)
29. Madonna P, de Stefano V, Coppola A, Cirillo F, Cerbone AM, Orefice G, et al. Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke. Stroke 2002;33:51-6. (Pubitemid 34052184)
30. Juul K, Tybjaerg-Hansen A, Steffensen R, Kofoed S, Jensen G, Nordestgaard BG. Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses. Blood 2002;100:3-10. (Pubitemid 35177420)
31. Zunker P, Hohenstein C, Plendl HJ, Zeller JA, Caso V, Georgiadis D, et al. Activated protein C resistance and acute ischaemic stroke: Relation to stroke causation and age. J Neurol 2001;248:701-4. (Pubitemid 32695868)
32. Grossmann R, Geisen U, Merati G, Müllges W, Schambeck CM, Walter U, Schwender S. Genetic risk factors in young adults with 'cryptogenic' ischemic cerebrovascular disease. Blood Coagul Fibrinolysis. 2002 Oct;13(7):583-90. (Pubitemid 35253353)
33. Lalouschek W, Aull S, Serles W, Schnider P, Mannhalter C, Lang T, et al. Genetic and nongenetic factors influencing plasma homocysteine levels in patients with ischemic cerebrovascular disease and in healthy control subjects. J Lab Clin Med 1999;133:575-82. (Pubitemid 29257220)
34. Slooter AJ, Rosendaal FR, Tanis BC, Kemmeren JM, van der Graaf Y, Algra A. Prothrombotic conditions, oral contraceptives, and the risk of ischemic stroke. J Thromb Haemost. 2005 Jun;3(6):1213-7. (Pubitemid 41725244)
35. Pezzini A, Del Zotto E, Archetti S, Negrini R, Bani P, Albertini A, et al. Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke. Stroke 2002;33:664-9. (Pubitemid 34203986)
36. McIlroy SP, Dynan KB, Lawson JT, Patterson CC, Passmore AP. Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke 2002;33:2351-6.
37. Topic E, Simundic AM, Ttefanovic M, Demarin V, Vuković V, Lovrencić-Huzjan A, et al. Polymorphism of apoprotein E (APOE), methylenetetrahydrofolate reductase (MTHFR) and paraoxonase (PON1) genes in patients with cerebrovascular disease. Clin Chem Lab Med 2001;39:346-50. (Pubitemid 32433336)
38. Eikelboom JW, Hankey GJ, Anand SS, Lofthouse E, Staples N, Baker RI. Association between high homocysteine and ischemic stroke due to large-and small artery disease but not other etiologic subtypes of ischemic stroke. Stroke 2000;31:1069-75. (Pubitemid 30253527)
39. Gross B, Antebi A, Cassel A, Honigman S. Is a mutation in the enzyme MTHFR a risk factor for stroke in young adults [abstract]? Neurology 2000;54(suppl3):A142.
40. MacLeod RS, Punske B, Yilmaz B, Shome S, Taccardi B. The role of heart rate in myocardial ischemia from restricted coronary perfusion. J Electrocardiol. 2001;34 Suppl:43-51. (Pubitemid 34083909)
41. Frikke-Schmidt R, Nordestgaard BG, Thudium D, Moes Grønholdt ML, Tybjaerg-Hansen A. APOE genotype predicts AD and other dementia but not ischemic cerebrovascular disease. Neurology. 2001 Jan 23;56(2):194-200. (Pubitemid 32095360)
42. Kessler C, Spitzer C, Stauske D, Mende S, Stadlmüller J, Walther R, Rettig R. The apolipoprotein E and betafibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease. Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2880-4. (Pubitemid 28016036)
43. Sudlow C, Martínez González NA, Kim J, Clark C. Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17,965 controls. Stroke. 2006 Feb;37(2):364-70. Epub 2005 Dec 29. (Pubitemid 43731988)
44. Banerjee I, Gupta V, Ganesh S. Association of gene polymorphism with genetic susceptibility to stroke in Asian populations: a meta-analysis. J Hum Genet. 2007;52(3):205-19. Epub 2006 Dec 14.
45. Pezzini A, Grassi M, Del Zotto E, Bazzoli E, Archetti S, Assanelli D, Akkawi NM, Albertini A, Padovani A. Synergistic effect of apolipoprotein E polymorphisms and cigarette smoking on risk of ischemic stroke in young adults. Stroke. 2004 Feb;35(2):438-42. (Pubitemid 38174426)
46. Baum L, Ng HK, Wong KS, Tomlinson B, Rainer TH, Chen X, Cheung WS, Tang J, Tam WW, Goggins W, Tong CS, Chan DK, Thomas GN, Chook P, Woo KS. Associations of apolipoprotein E exon 4 and lipoprotein lipase S447X polymorphisms with acute ischemic stroke and myocardial infarction. Clin Chem Lab Med. 2006;44(3):274-81. (Pubitemid 43357684)
47. McCarron MO, Delong D, Alberts MJ. APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis. Neurology. 1999 Oct 12;53(6):1308-11. (Pubitemid 29480092)